| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Foreclosures > Why Foreclosed Properties Sell at a Bargain |
|
Top Adding - Why Foreclosed Properties Sell at a Bargain
The good news about buying foreclosed properties is that they usually sell at a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product discounted price. It’s easy to find foreclosed properties being sold at 65% to 8 ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in 5% of its original price. On your lucky days, you can even find properties value lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. d at 50% of its original price! Many of you might be thinking, what is wrong wi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe th these properties that the owners are willing to sell at a bargain? Well, ther d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e is nothing really wrong about the properties except for the want of repairs an ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d cleaning up. Then why would the owner sell them? First, let us understand what easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi foreclosure is. Foreclosure takes place when a debtor used his or her property a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s security for a loan. In the event that the debtor fails to pay the loan, the c and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ reditor can foreclose the property used as security. For banks and financial ins ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi titutions, foreclosed properties are non-liquid assets. A bank or financing inst ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a itution would not want to keep properties, which are non-productive, or non-inco dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod me generating so they will sell them. Banks usually play by numbers, so, the mor cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e non-productive properties that a bank has, the greater the possibilities that tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ou can get one for as low as 50% of its original price. Why? Simple, the bank ne t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel eds to convert some or all of these non-productive assets into cash so that it c ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust an use it for business. Selling foreclosed properties at a bargain does not real y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ly mean a bank is losing money on the deal. Often times, the loans upon which th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ese properties have been used as collateral are already partially paid, thus, ev elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip en if the bank sells the property at a bargain, it can still realize good profit tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Friends and Family with Bipolar Disorder Business Success And The Art Of Networking
|